Home syrup of ipecac use does not reduce emergency department use or improve outcome.

摘要: Background. The usefulness of syrup ipecac as a home treatment for poisoning and the need to keep it in has been increasingly challenged. Many poison centers do not recommend any use ipecac. Objective. To determine if children at is associated with reduced utilization emergency department (ED) resources or improved outcome after unintended exposure pharmaceutical. Design. Cohort comparison. Setting. American Association Poison Control Centers’ Toxic Exposure Surveillance System Database. Patients. Blinded data each 64 US included ED referral recommendation rate, actual rate use, ipecac, outcome. These were derived from cases 2000 2001 involving Outcome Measures. Correlation between was primary sought. Rate adverse also compared. In addition, rates 7 specific identified compared published these same 1990 look trend practice this subgroup. Results. Mean 9% (range: 3%–18%). 1.8% 0.2%–14%). Increased (r = 0.18; 95% confidence interval r −0.06–0.41). Adverse rare: 0.6% 0.2%–2.1%). There no difference 2 groups 32 divided by relative use. centers, decreased mean 13.5% 8.1% 2000–2001. Ipecac 9.6% 2.1%. Conclusions. This study suggests there reduction resource improvement patient home. Although cannot exclude benefit very limited set poisonings, remains be proven.